Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search

Cardiovascular Pharmacology

Citations 101-110 of 221 total displayed.

Past content (since Feb 1999):

Articles
Opioid-Induced Cardioprotection Occurs via Glycogen Synthase Kinase {beta} Inhibition During Reperfusion in Intact Rat Hearts
Eric R. Gross, Anna K. Hsu, and Garrett J. Gross
Circ. Res. published February 19, 2004, doi:10.1161/01.RES.0000122392.33172.09 [Abstract]  

Molecular Medicine
Long-Term Treatment With a Specific Rho-Kinase Inhibitor Suppresses Cardiac Allograft Vasculopathy in Mice
Tsuyoshi Hattori, Hiroaki Shimokawa, Midoriko Higashi, Junko Hiroki, Yasushi Mukai, Kozo Kaibuchi, and Akira Takeshita
Circ. Res. 2004;94:46-52; published online before print as doi:10.1161/01.RES.0000107196.21335.2B [Abstract] [Full text]  

Cellular Biology
Agonist-Induced Activation of Matrix Metalloproteinase-7 Promotes Vasoconstriction Through the Epidermal Growth Factor–Receptor Pathway
Li Hao, Min Du, Ana Lopez-Campistrous, and Carlos Fernandez-Patron
Circ. Res. 2004;94:68-76; published online before print as doi:10.1161/01.RES.0000109413.57726.91 [Abstract] [Full text]  

Editorials
Hormonal Regulation of Normal Vascular Tone in Males
Michael E. Mendelsohn and Giuseppe M.C. Rosano
Circ. Res. 2003;93:1142-1145, doi:10.1161/01.RES.0000108694.68635.1C [Full text]  

Integrative Physiology
Impaired Acetylcholine-Induced Release of Nitric Oxide in the Aorta of Male Aromatase-Knockout Mice: Regulation of Nitric Oxide Production by Endogenous Sex Hormones in Males
Masahiko Kimura, Krishnankutty Sudhir, Margaret Jones, Evan Simpson, Ann-Maree Jefferis, and Jaye P.F. Chin-Dusting
Circ. Res. 2003;93:1267-1271; published online before print as doi:10.1161/01.RES.0000103172.98986.25 [Abstract] [Full text]  

Articles
Agonist-Induced Activation of Matrix Metalloproteinase-7 Promotes Vasoconstriction Through the Epidermal Growth Factor-Receptor Pathway
Li Hao, Min Du, Ana Lopez-Campistrous, and Carlos Fernandez-Patron
Circ. Res. published December 1, 2003, doi:10.1161/01.RES.0000109413.57726.91 [Abstract]  

Molecular Medicine
Pharmacological Activation of Normal and Arrhythmia-Associated Mutant KCNQ1 Potassium Channels
Guiscard Seebohm, Michael Pusch, Jun Chen, and Michael C. Sanguinetti
Circ. Res. 2003;93:941-947; published online before print as doi:10.1161/01.RES.0000102866.67863.2B [Abstract] [Full text]  

Articles
Long-Term Treatment With a Specific Rho-Kinase Inhibitor Suppresses Cardiac Allograft Vasculopathy in Mice
Tsuyoshi Hattori, Hiroaki Shimokawa, Midoriko Higashi, Junko Hiroki, Yasushi Mukai, Kozo Kaibuchi, and Akira Takeshita
Circ. Res. published November 13, 2003, doi:10.1161/01.RES.0000107196.21335.2B [Abstract]  

UltraRapid Communications
Rapid Effect of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition on Coronary Endothelial Function
Sven Wassmann, Anna Faul, Benno Hennen, Bruno Scheller, Michael Böhm, and Georg Nickenig
Circ. Res. 2003;93:e98-103e; published online before print as doi:10.1161/01.RES.0000099503.13312.7B [Abstract] [Full text]  

UltraRapid Communications
Does Nitric Oxide Mediate the Vasodilator Activity of Nitroglycerin?
Andrei L. Kleschyov, Matthias Oelze, Andreas Daiber, Yale Huang, Hanke Mollnau, Eberhard Schulz, Karsten Sydow, Birgit Fichtlscherer, Alexander Mülsch, and Thomas Münzel
Circ. Res. 2003;93:e104-112e; published online before print as doi:10.1161/01.RES.0000100067.62876.50 [Abstract] [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

* Subspecialty Collections Home

* Show  Cardiovascular Pharmacology
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment